Biosimilar Newsletter Archive

31. 10.08.19 -- Top Five Topics To Consider As You Advance Through Therapeutic Milestones 10/8/2019
    10/08/19 Biosimilar Development Newsletter
32. 10.03.19 -- How This Initiative Improved Biosimilar Infliximab Uptake 10/3/2019
    10/03/19 Biosimilar Development Newsletter
33. 09.26.19 -- Why This Biosimilar Initiative Is One To Watch 9/26/2019
    09/26/19 Biosimilar Development Newsletter
34. 09.24.19 -- 5 Ways To Optimize Biomanufacturing Process Efficiency Now 9/24/2019
    09/24/19 Biosimilar Development Newsletter
35. 09.19.19 -- What These 2 Policies Mean For Biosimilars 9/19/2019
    09/19/19 Biosimilar Development Newsletter
36. 09.12.19 -- Is It Time To Change The Biosimilar Regulatory Paradigm? 9/12/2019
    09/12/19 Biosimilar Development Newsletter
37. 09.10.19 -- Can Single-Use Film Be Optimized For The Entire Bioprocess Workflow? 9/10/2019
    09/10/19 Biosimilar Development Newsletter
38. 09.05.19 -- Breast Cancer Organization Highlights Biosimilars 9/5/2019
    09/05/19 Biosimilar Development Newsletter
39. 08.29.19 -- What Can Biosimilar Makers Learn From This Gene Therapy? 8/29/2019
    08/29/19 Biosimilar Development Newsletter
40. 08.28.19 -- Measuring Marketing Effectiveness: Defining And Implementing Credible Measurements 8/28/2019
    08/28/19 Biosimilar Development Newsletter